HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

Dorte Lisbet Nielsen, Michael Andersson, Claus Kamby

95 Citations (Scopus)

Fingerprint

Dive into the research topics of 'HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases